That was the week that was…. Your weekly market wrap (03-07 September)

Published 10-SEP-2018 11:22 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

It has been an interesting few months for the Australian market, with many stocks rising strongly on announcements, however, there were a number of companies that missed earnings expectations or downgraded their forecast and are now ‘worse for wear’. Some companies are likely to have been oversold. Good stocks will continue to rise.

The major theme for the corporate reporting season is that it proved to be a positive influence on the Australian market.

Interestingly, if you compare the performance of the market this year to the prior year, it has performed significantly better in 2018, post reporting season. Last year, the All Ordinaries Index (XAO) fell by around 3 per cent in August and continued to fall into November. This year, over the same period, the market has risen by around 1 per cent.

As with every reporting season there are winners and losers.

The Winners this reporting season include; Credit Corp Group (CCP), JB Hi-Fi Limited (JBH), Telstra Corporation Ltd (TLS), TPG Telecom Ltd (TPM), Afterpay Touch Group Ltd (APT) and Webjet Limited (WEB).

Those who were not so lucky included; Rio Tinto Limited (RIO), Iluka Resources Limited (ILU), Origin Energy Ltd (ORG), Ansell Limited (ANN), Flight Centre Travel Group Ltd (FLT) and Fortescue Metals Group (FMG).

Looking at the reporting season summary, around 50 per cent of companies beat analyst expectations, while only 20 per cent were below expectations. Looking back at the same period in 2017, approximately 40 per cent were ahead, while around 30 per cent missed the mark. Given this, our market has had a good reporting season.

So what do we expect in the market?

The All Ordinaries Index (XAO) traded down this week by around 3 per cent. The market opened at 6,428 points on Monday before trading down towards approximately 6,216 points during trade on Friday. This pullback is to be expected. The market has risen for 21 weeks to the recent high of 6,481 points. When the market is bullish, it will typically rise between 15 and 22 weeks before it pulls back for a number of weeks.

Overall, I believe that the outlook for the Australian market is likely to remain largely positive in the medium-term. It is probable for the XAO to achieve a new all-time high in the first half of 2019.

Good luck and good trading!

Dale Gillham, Chief Analyst at Wealth Within and Author of Accelerate Your Wealth.

This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X